245 related articles for article (PubMed ID: 21764210)
1. Re: Daher C. Chade, Shahrokh F. Shariat, Angel M. Cronin, et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur urol 2011;60:205-10.
Qin X; Ye D
Eur Urol; 2011 Oct; 60(4):e34. PubMed ID: 21764210
[No Abstract] [Full Text] [Related]
2. Re: Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade, et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010;58:574-580.
Chung SD; Wang SM; Chueh SC
Eur Urol; 2011 Jan; 59(1):e2. PubMed ID: 20980096
[No Abstract] [Full Text] [Related]
3. Re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038.
Froehner M; Koch R; Wirth MP
Eur Urol; 2015 Nov; 68(5):e103. PubMed ID: 26318708
[No Abstract] [Full Text] [Related]
4. Re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A multinational, multi-institutional study comparing positive surgical margin rates among 22,393 open, laparoscopic, and robot-assisted radical prostatectomy patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.11.018.
Giannarini G; Suardi N; Briganti A
Eur Urol; 2014 Jun; 65(6):e89-90. PubMed ID: 24447574
[No Abstract] [Full Text] [Related]
5. Reply to Gianluca Giannarini, Nazareno Suardi and Alberto Briganti's letter to the editor re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A multinational, multi-institutional study comparing positive surgical margin rates among 22 393 open, laparoscopic, and robot-assisted radical prostatectomy patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.11.018.
Sooriakumaran P; Wiklund P; Roobol MJ; Steyerberg E; Sanchez-Salas R; Cathelineau X; Tewari AK
Eur Urol; 2014 Jun; 65(6):e91-2. PubMed ID: 24447573
[No Abstract] [Full Text] [Related]
6. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038.
Rieken M; Shariat SF
Eur Urol; 2015 Nov; 68(5):e104-5. PubMed ID: 26314617
[No Abstract] [Full Text] [Related]
7. Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade, et al. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 2010;58:645-651.
Chung SD; Tsai YC; Chen KH
Eur Urol; 2011 Jan; 59(1):e3. PubMed ID: 20980097
[No Abstract] [Full Text] [Related]
8. Re: Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010;58:574-80.
Mouracade P
Eur Urol; 2011 Apr; 59(4):e23. PubMed ID: 21255908
[No Abstract] [Full Text] [Related]
9. Re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. Eur Urol 2016;70:588-96: Testing the Utility of Genomic Scores in the Setting of Recurrent Prostate Cancer After Radical Prostatectomy: We Can Certainly Do Better.
Fossati N; Gandaglia G; Bossi A; Montorsi F; Briganti A
Eur Urol; 2016 Oct; 70(4):e108-e109. PubMed ID: 26992282
[No Abstract] [Full Text] [Related]
10. Re: Lorenzo Marconi, Thomas Stonier, Rafael Tourinho-Barbosa, et al. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol 2019;76:27-30: Salvage Robotic Radical Prostatectomy for Recurrent Prostate Cancer After Focal Therapy.
Marra G; Van Velthoven R; Valerio M
Eur Urol; 2020 Apr; 77(4):e103-e104. PubMed ID: 31607392
[No Abstract] [Full Text] [Related]
11. Reply from authors re: Martin Spahn, Steven Joniau. Positive surgical margin at radical prostatectomy: futile or surgeon-dependent predictor of prostate cancer death? Eur Urol 2013;64:26-8: adjuvant versus salvage radiotherapy in patients with positive surgical margins at radical prostatectomy: that is the question.
Mauermann J; Fradet V; Fradet Y
Eur Urol; 2013 Jul; 64(1):28-9. PubMed ID: 23159455
[No Abstract] [Full Text] [Related]
12. Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
Achard V; Dal Pra A; Zilli T
Eur Urol; 2020 Dec; 78(6):e221-e222. PubMed ID: 33008661
[No Abstract] [Full Text] [Related]
13. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
[TBL] [Abstract][Full Text] [Related]
14. Re: Alessandro Sciarra, Valeria Panebianco, Stefano Salciccia, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008;54:589-600.
Casciani E; Bertini L; Gualdi G
Eur Urol; 2009 Jan; 55(1):e2-3; author reply e4-5. PubMed ID: 18572302
[No Abstract] [Full Text] [Related]
15. Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
Bravi CA; Montorsi F; Briganti A
Eur Urol; 2020 Dec; 78(6):e223-e224. PubMed ID: 33023772
[No Abstract] [Full Text] [Related]
16. Re: Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy: C. Von Bodman, G. Godoy, D. C. Chade, A. Cronin, L. J. Tafe, S. W. Fine, V. Laudone, P. T. Scardino and J. A. Eastham J Urol 2010; 184: 143-148.
Cai T; Nesi G; Malossini G; Bartoletti R
J Urol; 2011 Jan; 185(1):360-1; author reply 361. PubMed ID: 21092995
[No Abstract] [Full Text] [Related]
17. Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039.
Alongi F; Aiello D; Mazzola R; Cavalleri S
Eur Urol; 2017 Aug; 72(2):e39-e40. PubMed ID: 28318727
[No Abstract] [Full Text] [Related]
18. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy.
Leibovici D; Chiong E; Pisters LL; Guo CC; Ward JF; Andino L; Prokhorova IN; Troncoso P
J Urol; 2012 Jul; 188(1):98-102. PubMed ID: 22578724
[TBL] [Abstract][Full Text] [Related]
19. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
Vaidya A; Soloway MS
J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
[TBL] [Abstract][Full Text] [Related]
20. Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur urol 2014;65:546-51.
De Bari B; Arcangeli S; Alongi F
Eur Urol; 2015 Feb; 67(2):e26. PubMed ID: 25281388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
